Figure 3 Birt–Hogg–Dubé (BHD) renal tumour histology

Slides:

Advertisements

Similar presentations

© 2009 NHS National Genetics Education and Development CentreGenetics and Genomics for Healthcare Turner Syndrome Clinical.

Advertisements

Regional Perspectives on Renal Cell Carcinoma Mohamed Abdulla M.D. Professor of Clinical Oncology Cairo University AfME. September 17 th 2010W:

NEW APPROACHES IN CANCER PATHOLOGY - LESSONS FROM RENAL CARCINOMA STEWART FLEMING UNIVERSITY OF DUNDEE.

Management of T1 Kidney Cancer Laparoscopic Surgery

Data from The Johns Hopkins Renal Mass Registry

Kidney Cancer Like other cancers, kidney or “renal cell” cancer has a family history in 4% of the cases. Familial kidney cancers, like sporadic cases,

Nat. Rev. Urol. doi: /nrurol

Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.

Nat. Rev. Urol. doi: /nrurol

Normal kidney This fat is normal.

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Figure 2 Recruitment of experts to the Delphi study

Figure 1 The UMBRELLA SIOP-RTSG 2016 protocol logo

Figure 2 Multiscale modelling in oncology

Figure 1 Cellular processes involved in cancer development

Figure 5 Schematic illustration of different clinical trial designs

Nat. Rev. Urol. doi: /nrurol

Figure 3 Semantic model of the active surveillance (AS) timeline

Figure 1 Postulated mechanisms of action of PD‑1, PD‑L1 and PD‑L2

Nat. Rev. Nephrol. doi: /nrneph

Figure 5 Identification of mucinous carcinoma

Figure 2 Representative images from a right radical

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Figure 1 Proposed treatment algorithm for advanced gastroesophageal cancer based on publish recommendations Figure 1 | Proposed treatment algorithm for.

Nat. Rev. Urol. doi: /nrurol

Figure 1 The burden of chronic kidney disease (CKD)

Management of advanced renal cancer

Figure 2 Glomerular pathology in mice and humans with diabetic nephropathy Figure 2 | Glomerular pathology in mice and humans with diabetic nephropathy.

Figure 2 Podocyte dysfunction is a common feature of renal injury

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Molecular Tumour Profiling for Detection of Biomarkers in Renal Cell Tumours Kerstin Junker, Jimsgene Sanjmyatav, Joerg Mueller, Thomas Steiner, Heiko.

Nat. Rev. Urol. doi: /nrurol

Figure 2 Schema for the phase II Randomized Observation versus

Figure 1 The development process of the Asian

Figure 13 Proposed management of bladder cancer with variant histology

Figure 3 Algorithm for the determination of the clinical

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Nephrol. doi: /nrneph

Figure 6 Image sequence demonstrating coronal cuts on MRI

Nat. Rev. Urol. doi: /nrurol

Figure 2 White matter hyperintensities

Nat. Rev. Urol. doi: /nrurol

Figure 3 Differences in renal cell carcinoma (RCC) between genders

Figure 1 Changes in LUT function associated with ageing

the SNP profile using 26 prostate cancer GWAS risk SNPs

Hala Faragalla, Youssef M

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Figure 12 Cardiac gossypiboma

Nat. Rev. Urol. doi: /nrurol

Figure 1 A hierarchy of steps need to be

Nat. Rev. Urol. doi: /nrurol

A) Low magnification histopathological biopsy showing typical features of usual interstitial pneumonia pattern with a heterogeneous appearance and areas.

Nat. Rev. Urol. doi: /nrurol

Figure 4 The grey zone between active

Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol

Figure 1 Overview of the imaging biomarker roadmap

Nat. Rev. Urol. doi: /nrurol

Increased risk of solid renal tumors in lithium-treated patients

Significant pathological changes and activation of Nrf2 pathway in the glomeruli of human diabetic nephropathy patients. Significant pathological changes.

Presentation transcript:

Figure 3 Birt–Hogg–Dubé (BHD) renal tumour histology Figure 3 | Birt–Hogg–Dubé (BHD) renal tumour histology. a | Hybrid oncocytic tumour; ×150 magnification. b | Chromophobe renal tumour with characteristic perinuclear halos; ×150 magnification. c | Clear cell renal tumour. d | Renal oncocytoma in a BHD patient; ×150 magnification. e | Renal oncocytosis in normal kidney parenchyma of a BHD patient; ×100 magnification. Images are provided courtesy of Dr Maria J. Merino, Laboratory of Pathology, National Cancer Institute, National Institutes of Health. Images are provided courtesy of Dr Maria J. Merino, Laboratory of Pathology, National Cancer Institute, National Institutes of Health Schmidt, L. S. & Linehan, W. M. (2015) Molecular genetics and clinical features of Birt–Hogg–Dubé syndrome Nat. Rev. Urol. doi:10.1038/nrurol.2015.206